Gastroesophageal reflux disease (GERD) is one of the most common disorders of the gastrointestinal tract, with a pooled prevalence of 21% in the U.S., accounting for more than 4.6 million ambulatory ...

A New Drug Application for the EE and NERD indications for tegoprazan will be submitted in the fourth quarter of 2025. Topline data were announced from the maintenance phase of a phase 3 trial ...

Gastroesophageal reflux disease affects millions of people who rely on prescription antacids for relief, often unaware that natural methods can provide permanent solutions without medication ...

The FDA approved vonoprazan (Voquezna) for all grades of erosive gastroesophageal reflux disease (GERD) and heartburn relief associated with the condition, Phathom Pharmaceuticals announced on ...

Tegoprazan was superior to the proton pump inhibitor (PPI) lansoprazole in rapidly healing all grades of erosive esophagitis (EE), maintenance of healing, and relieving heartburn symptoms in patients ...

When you have an irritated or inflamed esophagus, also known as esophagitis, eating, drinking, and swallowing can be very painful. In most cases, your esophagus will heal on its own, but in the ...

Acid reflux, also known as gastroesophageal reflux, is a common condition that occurs when stomach acid flows back into the oesophagus and throat. This unpleasant condition can lead to a burning ...

How Do I Take Voquezna? Voquezna is an oral tablet that is taken once daily for GERD or erosive esophagitis and twice daily for H. pylori. Voquezna can be taken with or without food. Your doctor will ...

"It's our goal to better understand as many of the underlying causes of eosinophilic esophagitis as possible so that we can work toward therapeutic interventions to correct these issues and improve ...